BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura.
Case Rep Med
; 2022: 5603919, 2022.
Article
en En
| MEDLINE
| ID: mdl-35464782
ABSTRACT
Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe ITP with a platelet count of 0 after receiving the second dose of the BNT162b2 mRNA COVID-19 vaccine (also known as the Pfizer BioNTech). She subsequently recovered with a prolonged treatment course.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Case Rep Med
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos